Lifestyle Intervention for Treatment of Diabetes

NCT ID: NCT01806727

Last Updated: 2018-08-15

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 260 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2013-04-30
• Study Completion Date: 2017-03-30

Brief Summary

This study is evaluating two approaches to improving the control blood sugar, and other risk factors for heart disease in overweight and obese adults with type 2 diabetes. The first approach has participants focus on weight loss via reducing food intake and increasing physical activity, while attending weekly group sessions led by trained community health workers for 12 months. The second approach has participants receive education on diabetes self management, which focuses primarily on glucose control, while attending monthly group sessions led by a study staff member for 12 months. We are recruiting persons with type 2 diabetes who live in the Winston-Salem/Forsyth County area of North Carolina who are willing to attend sessions at the Downtown Health Plaza of Wake Forest Baptist Health. We will measure risk factors for heart disease (glucose control, blood pressure, blood cholesterol) and calculate the predicted risk of heart disease, and see which intervention lowers risk to a greater extent at 12 months, as well as 24 months.

Detailed Description

The Look AHEAD trial has demonstrated improved risk factor control among overweight or obese diabetes patients who received an intensive lifestyle intervention at both one and four years after enrollment. Translating such findings into accessible and effective weight loss programs is a major public health challenge. We are conducting "Lifestyle Interventions for Treatment of Diabetes" (LIFT Diabetes). The overall goal is to investigate two approaches to improving risk factor control; one which is modeled after Look AHEAD and is designed to achieve 7% weight loss and increase physical activity to > 175 minutes per week among minority and lower income diabetes patients via a 12-month, group based lifestyle intervention, using community health workers supervised by an interventionist. Participants will have up to 4 group visits/month and up to 12 individual contacts/year. The other approach will promote Diabetes Self Management (DSM) by educating participants regarding health behaviors which lead to improved diabetes control; this arm is also 12 months, and is delivered in the clinic by intervention staff via monthly group visits and up to 12 individual contacts/year. We will randomize 260 overweight or obese adults with diabetes to either intervention, and determine the impact on outcomes (UKPDS-estimated CVD risk, risk factor control), weight, cost, resource utilization, and safety at 12 months, and after transitioning back to usual care, at 24 months. The hypotheses are that the community based intervention results in 10% relative reduction in CVD risk compared to clinic-based intervention; the interventions are equivalent with respect to adherence and participant satisfaction; and the community based intervention is associated with lower cost than the clinic based intervention. Translating evidence based, lifestyle strategies, and targeting minority and underserved patients, will yield, if successful, models for addressing diabetes-related health disparities.

Conditions

Type 2 Diabetes; Overweight; Obesity

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: NONE

Study Groups

Diabetes Self Management (DSM)

Diabetes Self Management education, delivered in the clinics, using group-based visits and targeting improved control of hemoglobin A1c and related risk factors.

Group Type: ACTIVE_COMPARATOR

Community Lifestyle Weight Loss (LWL)

Intervention Type: BEHAVIORAL

Changing dietary and physical activity behavior to promote weight loss

Community Lifestyle Weight Loss (LWL)

Participants with type 2 diabetes will be enrolled in a 12 month lifestyle intervention designed to achieve a mean \>7% weight loss induced through caloric restriction and increased physical activity. The intervention will be delivered via supervised Community Health Workers (CHWs). Most meetings will be at a community location.

Group Type: EXPERIMENTAL

Diabetes Self Management (DSM)

Intervention Type: BEHAVIORAL

Changing diet, physical activity, self monitoring, and medication related behaviors to improve diabetes control

Interventions

Community Lifestyle Weight Loss (LWL)

Changing dietary and physical activity behavior to promote weight loss

Intervention Type: BEHAVIORAL

Diabetes Self Management (DSM)

Changing diet, physical activity, self monitoring, and medication related behaviors to improve diabetes control

Intervention Type: BEHAVIORAL

Eligibility Criteria

Inclusion Criteria

• Men and women 21 years of age and older residing in the Forsyth County, North Carolina region.
• Disease: Type 2 diabetes mellitus.
• Overweight or obese: defined as body mass index (BMI) greater than 25 kg/m2 (>27 if on insulin).
• If not on diabetes medication, persons with hemoglobin A1c greater than or equal to 6.5% and less than 11.0%
• If on diabetes medication, hemoglobin A1c greater than or equal to 5.0% and less than 11.0%
• Blood pressure: BP ≤ 160/100 mmHg.
• A usual source of medical care: The intervention may induce hypoglycemia and have other risks, and weight loss and increased physical activity may modify the need for drugs used to treat diabetes, high blood pressure, and lipids. Patients must have a source for ongoing care. Usual source of care will be documented via a "medical clearance" form with physician signature verifying that MD is aware their patient is participating in this trial.
• Able to exercise: Increasing moderate intensity physical activity is an integral part of this intervention. Must be able to walk 1/4 mile without assistance.
• Able to communicate in English
• Other: Willing to give consent to participate in this research program, including random allocation to either study arm.

Exclusion Criteria

• Poorly controlled diabetes: defined by hemoglobin A1c>11%
• Cardiovascular disease: Clinical history of cardiovascular disease, or newly diagnosed at screening. This includes myocardial infarction, heart failure, ischemic heart disease, stroke and other vascular disease. Persons suspected of having angina (chest pain) or other potentially ischemic symptoms will be required to be evaluated by their health care provider.
• Weight Loss: Currently involved in a supervised medical or surgical weight loss program or with a history of prior weight loss surgery.
• Age: We will exclude children (<21 years)
• Serious Illness with anticipated decreased life expectancy during the 2 year (24 month) time frame of the intervention, such as cancer diagnosis or treatment within the past 5 years (with the exception of non-melanoma skin cancer).
• Inability to exercise: Patients who are wheel chair bound, have had an amputation, are undergoing treatment for lower extremity infections, or who self report being unable to ambulate 400 meters (1/4 mile) without assistance.
• Participation in another clinical trial involving intervention(s) which affect any component of cardiovascular risk. Potential participants who are enrolled in purely observational studies remain eligible.
• Renal disease: Persons with stage 3 chronic renal disease (estimated glomerular filtration rate <60ml/min by the chronic kidney disease formula used by Wake Forest Baptist) will be excluded.
• Other: Conditions/criteria likely to interfere with participation and acceptance of randomized assignment, including the following: inability/unwillingness to give informed consent, major psychiatric or cognitive problems (schizophrenia, dementia), self-reported active illegal substance or alcohol abuse, and clinical judgment.

• Minimum Eligible Age: 21 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

National Institute on Minority Health and Health Disparities (NIMHD)

NIH

Sponsor Role: collaborator

Wake Forest University

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Alain G Bertoni, MD MPH

Role: PRINCIPAL_INVESTIGATOR

Wake Forest University Health Sciences

Jeffrey Katula, PhD

Role: PRINCIPAL_INVESTIGATOR

Wake Forest University

Locations

Wake Forest Baptist Health

Winston-Salem, North Carolina, United States

Countries

United States

References

Claudel SE, Bertoni AG. Exploring the Use of Personal Technology in Type 2 Diabetes Management Among Ethnic Minority Patients: Cross-Sectional Analysis of Survey Data from the Lifestyle Intervention for the Treatment of Diabetes Study (LIFT Diabetes). JMIR Diabetes. 2018 Feb 22;3(1):e5. doi: 10.2196/diabetes.8934.

Reference Type: DERIVED

PMID: 30291086 (View on PubMed)

Effoe VS, Katula JA, Kirk JK, Pedley CF, Bollhalter LY, Brown WM, Savoca MR, Jones ST, Baek J, Bertoni AG; LIFT Diabetes Research Team. The use of electronic medical records for recruitment in clinical trials: findings from the Lifestyle Intervention for Treatment of Diabetes trial. Trials. 2016 Oct 13;17(1):496. doi: 10.1186/s13063-016-1631-7.

Reference Type: DERIVED

PMID: 27733193 (View on PubMed)

Other Identifiers

1P60MD006917-01

Identifier Type: NIH

Identifier Source: secondary_id

View Link

IRB00022613

Identifier Type: -

Identifier Source: org_study_id